Motor Neurone Disease (MND) is a debilitating neurodegenerative disease that affects the brain and spinal cord, leading to the death…
Read More
Filter By
Conscious uncomplicating? Is the end to ‘backup’ trade mark filings in China in sight?
Under the current practice of the China National Intellectual Property Administration (CNIPA), the suspension of a trade mark application is…
Read More
Barker Brettell ready to lead client representation at the UPC after confirmation that English will be a language option
With the Unified Patent Court (UPC) having opened its doors on 1 June 2023, heralding a new era for patent…
Read More
Why the EPO’s Enlarged Board of Appeal’s decision in G2/21 will impact inventions relating to life sciences and chemistry
The European Patent Office’s (EPO) Enlarged Board of Appeal’s decision in G2/21 primarily relates to when data that only becomes…
Read More
Giving notice: enforcing your IP rights when an employee leaves with more than their P45
A resignation letter has been submitted. The Director, who joined the business in its infancy and has been part of…
Read More
Unified Patent Court and Unitary Patent go live on 1 June 2023
Germany has today ratified the UPC Agreement meaning the go-live date for the Unitary Patent (UP) and the Unified Patent Court…
Read More
Safeguarding creativity: the fundamental principles of IP
Intellectual Property (IP) always seems to pique media attention. In 2022, brands such as Red Bull and Zara hit the headlines…
Read More
UK IPO announces address for service changes with immediate effect
Background The UK IPO’s approach in handling communications arising out of third-party actions filed against UK trade mark and design…
Read More
Get ready for the Unitary Patent and Unified Patent Court to go live: 1 June 2023
The current go-live date for the Unitary Patent (UP) and the Unified Patent Court (UPC) is 1 June 2023. For…
Read More
When M&A goes bad: overlook IP due diligence at your peril
According to a Harvard Business Review article, “Deal making is glamorous; due diligence is not”. Do you think this is…
Read More
Lecanemab: could the drug with modest benefits make a big difference to Alzheimer’s patients?
Currently more than 55 million people live with dementia worldwide, with the number of people living with the disease expected to triple…
Read More
What happens when your cosmetic method gives rise to therapeutic effects?
There are many innovations in the cosmetic sector that can be the subject of patent applications and these may be…
Read More